PHR1817
Furosemide Related Compound A
Pharmaceutical Secondary Standard; Certified Reference Material
Sinónimos:
2-Chloro-4-furfurylamino-5-sulfamoylbenzoic acid, 2-CHLORO-4-N-FURFURYLAMINO -5-SULFAMOYLBENZOIC ACID
About This Item
Productos recomendados
grade
certified reference material
pharmaceutical secondary standard
Quality Level
agency
traceable to Ph. Eur. F0702000
traceable to USP 1287020
CofA
current certificate can be downloaded
packaging
pkg of 100 mg
mp
197 °C (dec.) (lit.)
application(s)
pharmaceutical
format
neat
storage temp.
2-30°C
SMILES string
OC(C1=C(Cl)C=C(NCC2=CC=CO2)C(S(N)(=O)=O)=C1)=O
InChI
1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)11(21(14,18)19)4-8(9)12(16)17/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)
InChI key
UXOOVYKVEXGCSH-UHFFFAOYSA-N
¿Está buscando productos similares? Visita Guía de comparación de productos
General description
Application
- Furosemide Impurity A for Quality Control: Furosemide Related Compound A serves as a crucial standard in pharmaceutical quality control, ensuring the purity and safety of furosemide as an active pharmaceutical ingredient. This impurity standard is essential for regulatory compliance and batch-to-batch consistency in drug manufacturing (Abasilim et al., 2023).
- Research on Drug Resistance: Furosemide Related Compound A is utilized in genomic research to identify potential drug resistance mechanisms. This research aids in understanding how bacterial pathogens develop resistance to drugs like clarithromycin and rifampicin, which is crucial for developing new therapeutic strategies (Mofidifar et al., 2024).
- Nanotechnology in Drug Delivery: High-purity Furosemide Related Compound A is used in the preparation and characterization of novel drug delivery systems, such as nanoparticles designed to enhance the bioavailability and efficacy of pharmaceutical compounds. This research highlights its application in improving drug formulations and targeting specific disease sites (Zeng et al., 2024).
- Impact on Bone Health: Research involving Furosemide Related Compound A explores its effects on bone health, particularly in how it influences vitamin D metabolism and bone density. This is vital for developing treatments that mitigate bone density loss associated with long-term use of diuretics like furosemide (Melanie KF et al., 2024).
- Nutritional Studies in Cancer Therapy: Furosemide Related Compound A is also examined for its role in nutritional interventions in cancer therapy, particularly its impact on the nutritional status of patients undergoing surgery for colorectal cancer. These studies are crucial for understanding how nutritional support can enhance recovery and treatment outcomes in cancer patients (Ural et al., 2024).
Analysis Note
Other Notes
Footnote
Recommended products
Storage Class
11 - Combustible Solids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Certificados de análisis (COA)
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Los clientes también vieron
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico